Skip to main content

Leucovorin News

Ipsen’s Onivyde Regimen, a Potential New Standard-of-Care First-Line Therapy in Metastatic Pancreatic Adenocarcinoma, Approved by FDA

PARIS, FRANCE, 13 February 2024 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application for Onivyde (...

FDA Medwatch Alert: Leucovorin Calcium Injection (Bedford Laboratories): Recall - Visible Particulate Matter

  [Posted 07/06/2012] ISSUE: Bedford Laboratories issued a nationwide recall of three lots of Leucovorin Calcium Injection, due to the discovery of visible crystalline particulate matter in a small ...

FDA Approves Fusilev for Use in Patients with Colorectal Cancer

IRVINE, Calif.--(BUSINESS WIRE)--Apr 30, 2011 - Spectrum Pharmaceuticals a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology,...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Colorectal Cancer

Leucovorin patient information at Drugs.com